Palavra-chave: 6-NITRODOPAMINE

SILODOSIN EPIDIDYMAL VAS DEFERENS DOXAZOSIN TAMSULOSIN ALFUZOSIN CATECHOLAMINES ADRENOCEPTORS L-761,626 L-NAME CHELONOIDIS CARBONARIA DOPAMINE RECEPTORS AORTA ATRIA DOPAMINE HALOPERIDOL ODQ ENDOTHELIUM PULMONARY ARTERY L-741,626 IDAZOXAN PRE-SYNAPTIC ADRENOCEPTORS TETRODOTOXIN VAS DEFERENS CHRONOTROPISM VENTRICLE ENDOTHELIAL NITRIC OXIDE SYNTHASE PHOSPHODIESTERASE PROTEIN KINASE A NITRIC OXIDE HUMAN VAS DEFERENS EJACULATION LANGENDORFF'S PREPARATION LEFT VENTRICULAR DEVELOPED PRESSURE INOTROPISM ATENOLOL ELECTRICAL-FIELD STIMULATION EPITHELIUM SEMINAL VESICLES FLUORESCENCE IN-SITU HYBRIDIZATION ASSAYS CORPUS CAVERNOSUM NEURONAL NITRIC OXIDE SYNTHASE 6-CYANODOPAMINE TYROSINE HYDROXYLASE DOPAMINERGIC D2-LIKE RECEPTOR RESISTANCE VESSELS RAT ISOLATED RIGHT ATRIUM ADRENOCEPTOR ANTAGONISTS ( ±)-4-NO2-PROPRANOLOL, ISOLATED URINARY BLADDER INDUCIBLE NITRIC OXIDE SYNTHASE TANDEM MASS SPECTROMETRY CATECHOLAMINE SOLUBLE GUANYLATE CYCLASE GKT137831 RAT ISOLATED SEMINAL VESICLES FLUORESCENCE IN SITU HYBRIDIZATION LC-MS/MS HUMAN ISOLATED VAS DEFERENS FLUORESCENCE IN-SITU HYBRIDIZATION